We evaluate over-the-counter hearing aids on the four dimensions that determine whether a device actually gets worn every day: speech clarity, ease of use, personalization, and consumer protection. The full scoring rubric is on our methodology page.
Last reviewed: May 13, 2026 · Reviewed by: Dr Jeffrey Smith, AuD, Editor-in-Chief
The 2026 framework scores OTC hearing aids on Speech Clarity, Ease of Use, Personalization, and Consumer Protection — each weighted 25/100. A score of 85+ indicates a strong candidate for most adults with perceived mild-to-moderate hearing loss. The framework is reviewed against the FDA OTC Final Rule, the WHO World Report on Hearing, and recent peer-reviewed evidence on self-fit OTC outcomes. Our current editor's picks against this framework are at /picks.
Each area is scored from 0–25 for a total of 100. We weight speech clarity and ease of use most heavily because they are the strongest predictors of long-term daily wear.
| Evaluation Area | Why It Matters | What We Look For | Weight |
|---|---|---|---|
| Speech Clarity | Most users want better conversations, not just louder sound. Untreated speech-in-noise difficulty is the single most common daily-life complaint among adults with age-related hearing loss. | Multi-channel processing, directional microphones, noise reduction, feedback control. | 25 / 100 |
| Ease of Use | Many seniors abandon hearing aids that are complicated to put in, charge, or operate. Simple, reliable daily use is what keeps a device in the ear. | Rechargeable design, simple physical controls, clear printed instructions, accessible app. | 25 / 100 |
| Personalization | Two people with similar audiograms may need very different amplification. Devices that adapt to the wearer outperform fixed-profile devices. | Self-administered hearing test, app-based fine tuning, frequency-band control, environment presets. | 25 / 100 |
| Consumer Protection | Hearing aids are a significant purchase. Trial periods and warranties shift risk from buyer to seller and signal the seller's confidence. | At least 45-day home trial, 1-year+ warranty, U.S.-based phone support, transparent return policy. | 25 / 100 |
Since the FDA's OTC rule took effect in October 2022, the consumer market has organized into four broad product categories.
Small, often invisible devices that calibrate to the wearer through an in-app hearing test and frequency-band tuning. Best for adults comfortable with smartphones and looking for discretion. Trade-off: tighter fit can feel occluded at first.
Example: Panda Stealth ($279) — near-invisible ITC, 16-channel processing, three preset modes, no app required.
The receiver-in-canal form factor used by most prescription hearing aids, now available OTC. Better suited to higher-frequency loss and longer battery life. Trade-off: more visible.
Example: Panda Quantum ($349) — RIC, 16-channel WDRC, frequency-matched amplification, tinnitus masking.
Devices that ship with a small number of fixed sound profiles — no in-app test. Often the lowest-priced category. Trade-off: limited personalization, often a worse fit for asymmetric or sloping loss.
Examples: Audien Atom, MDHearing Volt — entry-level preset amplifiers commonly seen at $99–$300.
Hearing-aid-grade processing inside earbud hardware (in some cases also functioning as Bluetooth headphones). Useful for adults who want to ease into hearing support. Trade-off: shorter daily wear time and bigger fit.
Examples: Panda Air ($299) and Apple AirPods Pro 2 with the FDA-authorized Hearing Aid Feature ($249).
We deliberately do not score on:
The 2026 framework is reviewed annually. We re-score categories when:
See our editorial standards for the corrections policy and how we handle conflicts of interest.